Connection
Jennifer Kiser to Hepatitis B
This is a "connection" page, showing publications Jennifer Kiser has written about Hepatitis B.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.081 |
|
|
|
-
Smolders EJ, Burger DM, Feld JJ, Kiser JJ. Review article: clinical pharmacology of current and investigational hepatitis B virus therapies. Aliment Pharmacol Ther. 2020 01; 51(2):231-243.
Score: 0.635
-
Zhang HL, Mock M, Bushman L, Anderson PL, Kiser JJ, Naggie S. Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral Suppression. Clin Infect Dis. 2024 09 26; 79(3):705-708.
Score: 0.221
-
Thomas DL, Kiser JJ, Baum MM. Long-Acting Treatments for Hepatitis B. Clin Infect Dis. 2022 11 21; 75(Suppl 4):S517-S524.
Score: 0.194
-
Wong TC, Lan A, Kiser JJ, Anderson PL, Patel K, Tillman H, Naggie S. Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression. Hepatology. 2016 09; 64(3):999-1000.
Score: 0.031